Ventricular Unloading, Tissue Angiotensin II, Matrix Modulation, and Function During Left Ventricular Assist Device Support**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 49, Issue 11, 2007, Pages 1175-1177

  Jugdutt, Bodh I ^a   Butler, Craig ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CLENBUTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

CELL FUNCTION; DIASTOLIC DYSFUNCTION; EDITORIAL; EXTRACELLULAR MATRIX; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FEMALE; FORECASTING; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR REMODELING;

EID: 33947170694     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.12.022     Document Type: Editorial

References (10)

1. Rose E.A., Gelijns A.C., Moskowitz A.J., et al., Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
2. Stevenson L.W., Miller L.W., Desvigne-Nickens P., et al., REMATCH Investigators. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 110 (2004) 975-981
3. Jugdutt B.I. Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Curr Drug Targets Cardiovasc Haematol Disord 3 (2003) 1-30
4. Manabe I., Shindo T., and Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91 (2002) 1103-1113
5. Klotz S., Foronjy R.F., Dickstein M.L., et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 112 (2005) 364-374
6. Bruggink A.H., van Oosterhout M.F., de Jonge N., et al. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant 25 (2006) 1091-1098
7. Peng H., Carretero O.A., Vuljaj N., et al. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation 112 (2005) 2436-2445
8. Ferrario C.M., Trask A.J., and Jessup J.A. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289 (2005) H2281-H2290
9. Klotz S., Danser A.H.J., Foronjy R.F., et al. The impact of angiotensin-converting-enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol 49 (2007) 1166-1174
10. Hon J.K., and Yacoub M.H. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg 75 Suppl (2003) S36-S41